28036301|t|ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women
28036301|a|Host immunogenetic background plays an important role in human papillomavirus (HPV) infection and cervical cancer development. Inositol 1,4,5-triphosphate receptor type 3 (ITPR3) is essential for both immune activation and cancer pathogenesis. We aim to investigate if ITPR3 genetic polymorphisms are associated with the risk of cervical cancer in Taiwanese women. ITPR3 rs3748079 A/G and rs2229634 C/T polymorphisms were genotyped in a hospital-based study of 462 women with cervical squamous cell carcinoma (CSCC) and 921 age-matched healthy control women. The presence and genotypes of HPV in CSCC was determined. No significant association of individual ITPR3 variants were found among controls, CSCC, and HPV-16 positive CSCC. However, we found a significant association of haplotype AT between CSCC and controls (OR = 2.28, 95% CI 1.31-3.97, P = 2.83 × 10-3) and the OR increased further in CSCC patients infected with HPV-16 (OR = 2.89, 95% CI 1.55-5.37, P = 4.54 × 10-4). The linkage disequilibrium analysis demonstrated that ITPR3 association with CSCC was independent of HLA-DRB1 alleles. In conclusion, these findings suggest that AT haplotype in the ITPR3 gene may serve as a potential marker for genetic susceptibility to CSCC.
28036301	0	10	ITPR3 gene	T017	UMLS:C1416519
28036301	40	72	cervical squamous cell carcinoma	T038	UMLS:C0279671
28036301	81	90	Taiwanese	T098	UMLS:C1556096
28036301	91	96	women	T098	UMLS:C0043210
28036301	97	115	Host immunogenetic	T091	UMLS:C0021005
28036301	154	190	human papillomavirus (HPV) infection	T038	UMLS:C0343641
28036301	195	222	cervical cancer development	T038	UMLS:C1516170
28036301	224	267	Inositol 1,4,5-triphosphate receptor type 3	T017	UMLS:C1416519
28036301	269	274	ITPR3	T017	UMLS:C1416519
28036301	298	315	immune activation	T038	UMLS:C1155000
28036301	320	326	cancer	T038	UMLS:C0006826
28036301	327	339	pathogenesis	T038	UMLS:C0699748
28036301	366	371	ITPR3	T017	UMLS:C1416519
28036301	372	393	genetic polymorphisms	T038	UMLS:C0032529
28036301	445	454	Taiwanese	T098	UMLS:C1556096
28036301	455	460	women	T098	UMLS:C0043210
28036301	462	467	ITPR3	T017	UMLS:C1416519
28036301	468	481	rs3748079 A/G	T082	UMLS:C0752046
28036301	486	513	rs2229634 C/T polymorphisms	T082	UMLS:C0752046
28036301	534	554	hospital-based study	T062	UMLS:C2603343
28036301	562	567	women	T098	UMLS:C0043210
28036301	573	605	cervical squamous cell carcinoma	T038	UMLS:C0279671
28036301	607	611	CSCC	T038	UMLS:C0279671
28036301	649	654	women	T098	UMLS:C0043210
28036301	686	689	HPV	T005	UMLS:C0021344
28036301	693	697	CSCC	T038	UMLS:C0279671
28036301	755	760	ITPR3	T017	UMLS:C1416519
28036301	761	769	variants	T017	UMLS:C0678941
28036301	797	801	CSCC	T038	UMLS:C0279671
28036301	807	822	HPV-16 positive	T033	UMLS:C4288937
28036301	823	827	CSCC	T038	UMLS:C0279671
28036301	897	901	CSCC	T038	UMLS:C0279671
28036301	994	998	CSCC	T038	UMLS:C0279671
28036301	1022	1028	HPV-16	T005	UMLS:C0999806
28036301	1081	1112	linkage disequilibrium analysis	T062	UMLS:C1517888
28036301	1131	1136	ITPR3	T017	UMLS:C1416519
28036301	1137	1148	association	T062	UMLS:C2717881
28036301	1154	1158	CSCC	T038	UMLS:C0279671
28036301	1178	1186	HLA-DRB1	T017	UMLS:C1415576
28036301	1187	1194	alleles	T017	UMLS:C0002085
28036301	1259	1269	ITPR3 gene	T017	UMLS:C1416519
28036301	1285	1301	potential marker	T038	UMLS:C0017393
28036301	1332	1336	CSCC	T038	UMLS:C0279671